Source: Eur Respir J, 55 (4) 2000267; 10.1183/13993003.00267-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Brian Lipworth, Chris RuiWen Kuo, Rory Chan. Making simple things complicated using anti-inflammatory reliever therapy. Eur Respir J, 55 (4) 2000267; 10.1183/13993003.00267-2020

Member's Comments

No comment yet.

Related content which might interest you: Budesonide/formoterol maintenance and reliever therapy for asthma in general practice: is it cost-effective? Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008 Formoterol as relief medication is increasingly more effective than salbutamol in patients with increasing need for reliever therapy Source: Eur Respir J 2003; 22: Suppl. 45, 235s Year: 2003 How to treat asthma in 2021? Goodbye SABA, hello MART and welcome triple therapy Source: Virtual Congress 2021 – Airway diseases Year: 2021 Use of relievers in patients with severe asthma on biologic therapy –a multidisciplinary approach Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020 Oral corticosteroids for asthma usually prescribed by non-specialists Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Time to ban short-acting ß-agonists and use anti-inflammatory treatment as required to improve outcomes Source: Virtual Congress 2021 – Wheezing illnesses along the life span Year: 2021 Next generation of anti-inflammatory therapy for COPD? Source: Eur Respir J, 50 (4) 1702084; 10.1183/13993003.02084-2017 Year: 2017 Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Source: Eur Respir J 2004; 24: 1-2 Year: 2004 Budesonide/formoterol single inhaler therapy reduces overreliance on rapid-acting reliever medication Source: Eur Respir J 2004; 24: Suppl. 48, 344s Year: 2004 Can " Beta-blockers" be useful to treat asthma? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 How often do asthma patients claim prescribed therapy? Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS Year: 2017 Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment Source: Eur Respir J 2015; 45: 260-262 Year: 2015 Optimising bronchodilator therapy in COPD: Who, why and when? Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 How effective are oral steroids in asthma action plans? Source: International Congress 2017 – Asthma management Year: 2017 How can we minimise the use of regular oral corticosteroids in asthma? Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019 Year: 2020 Is it time to move away from short-acting beta-agonists in asthma management? Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018 Year: 2019 Investigating the steroids and long-acting β2-agonists combination: why do we need more? Source: Eur Respir J 2004; 23: 501-502 Year: 2004 Budesonide/formoterol maintenance and reliever therapy compared to conventional best practice in the treatment of persistent asthma Source: Eur Respir J 2007; 30: Suppl. 51, 616s Year: 2007 Is there a problem with oral corticosteroid use in asthma? Source: Virtual Congress 2020 – Airway diseases Year: 2020